Results 151 to 160 of about 49,427 (236)

Frequent and clinically relevant germline DNA repair gene variants in young and familial myeloproliferative neoplasms. [PDF]

Blood Cancer J
Meyer R, Rodriguez MJ, Caduc M, Kricheldorf K, Begemann M, Kraft F, Spier I, Dey D, Güzel N, Becker K, Baumeister J, S de Toledo MA, Isfort S, Germing U, Aretz S, Brümmendorf TH, Kurth I, Elbracht M, Teichmann LL, Koschmieder S.   +19 more
europepmc   +1 more source

Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms

, 2015
Takuro Kameda, Kotaro Shide, Takumi Yamaji, Ayako Kamiunten, Masaaki Sekine, Tomonori Hidaka, Yoko Kubuki, Goro Sashida, Kazumasa Aoyama, Makoto Yoshimitsu, Hiroo Abe, Tadashi Miike, Hisayoshi Iwakiri, Yoshihiro Tahara, Shojiro Yamamoto, Satoru Hasuike, Kenji Nagata, Atsushi Iwama, Akira Kitanaka, Kazuya Shimoda   +19 more
openalex   +1 more source

NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms. [PDF]

Nat Commun
Koerber RM, Krollmann C, Cieslak K, Tregel E, Saenz ML, Brümmendorf TH, Koschmieder S, Griesshammer M, Gütgemann I, Baldauf CK, Fischer T, Brossart P, Kolbe CC, Latz E, Wolf D, Teichmann LL.   +15 more
europepmc   +1 more source

Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms

Haematologica, 2014
Luca Malcovati, Elisa Rumi, Mario Cazzola   +2 more
doaj   +1 more source

Proteomic profiling links complement activation to thrombosis in JAK2V617F myeloproliferative neoplasms. [PDF]

Transl Oncol
De Moner B, Martinez-Sanchez J, Escribano-Serrat S, Ramos A, Moreno-Castaño AB, Arellano-Rodrigo E, Escolar G, Carreras E, Álvarez-Larrán A, Diaz-Ricart M.   +9 more
europepmc   +1 more source

The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms [PDF]

, 2014
Zhiyuan Wu, Xinju Zhang, Xiao Xu, Yu‐Ming Chen, Tingting Hu, Zhihua Kang, Shibao Li, Hua Wang, Weiwei Liu, Xiaochao Ma, Ming Guan   +10 more
openalex   +1 more source

Targeting mitochondrial dysfunction in myeloproliferative neoplasms: current strategies and future directions - a narrative review. [PDF]

Ann Med Surg (Lond)
Dirani NA, Soufan F, Jebawi KA, Satea Shafeea M, Nasereldeen N, Sabra I, Mhanna Z, Sajjad W, Khalil A, Chaurasia B, Nasrallah J.   +10 more
europepmc   +1 more source

Treatment approach and outcomes of patients with accelerated/blast-phase myeloproliferative neoplasms in the current era [PDF]

Anand Patel, James Yoon, Hannah Johnston, Marta Davidson, Rory M. Shallis, Evan C. Chen, Madelyn Burkart, Timothy S. Oh, Sunil Iyer, Ellen Madarang, Chandrasekar Muthiah, Iyana Gross, Raven Dean, Joshua Kassner, Auro Viswabandya, Rafael Madero‐Marroquin, Raajit K. Rampal, Guru Subramanian Guru Murthy, Terrence Bradley, Yasmin Abaza, Jacqueline S. Garcia, Vikas Gupta, Kristen Pettit, John Cursio, Olatoyosi Odenike   +24 more
openalex   +1 more source

Aquagenic Pruritus Questionnaire: Predicting Myeloproliferative Neoplasms in Patients with Aquagenic Pruritus. [PDF]

Dermatol Ther (Heidelb)
Witte F, Weisshaar E, Metz M, Koschmieder S, Isfort S, Kremer AE, Griesshammer M, Royeck S, Ständer S, Zeidler C.   +9 more
europepmc   +1 more source

Gadd45g insufficiency drives the pathogenesis of myeloproliferative neoplasms [PDF]

Peiwen Zhang, Na You, Yiyi Ding, Wenqi Zhu, Nan Wang, Yueqiao Xie, Wanling Huang, Qian Ren, Tiejun Qin, Rongfeng Fu, Lei Zhang, Zhijian Xiao, Tao Cheng, Xiaotong Ma   +13 more
openalex   +1 more source